Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

David E. Gerber, M. Shaalan Beg, Farjana Fattah, Arthur E. Frankel, Oluwatomilade Fatunde, Yull Arriaga, Jonathan E. Dowell, Ajit Bisen, Richard D. Leff, Claudia C. Meek, William C. Putnam, Raja Reddy Kallem, Indhumathy Subramaniyan, Ying Dong, Joyce Bolluyt, Venetia Sarode, Xin Luo, Yang Xie, Brian Schwartz, David A. Boothman

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences